Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Dec 24, 2009

29777_dirs_2009-12-23_e55c5488-c113-42f1-964b-c93b4e242c6b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-11-12

Reporting Person: Hance Robert B (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-12-22 Common shares without par value M 18564 $51.91 Acquired 154058 Direct
2009-12-22 Common shares without par value M 42561 $41.0317 Acquired 196619 Direct
2009-12-22 Common shares without par value S 1300 $54.13 Disposed 195319 Direct
2009-12-22 Common shares without par value S 16380 $54.10 Disposed 178939 Direct
2009-12-22 Common shares without par value S 200 $54.11 Disposed 178739 Direct
2009-12-22 Common shares without par value S 684 $54.12 Disposed 178055 Direct
2009-12-22 Common shares without par value F 36449 $54.102 Disposed 141606 Direct
2009-11-12 Common shares without par value G 220 Disposed 141386 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-12-22 Option (right to buy) $51.91 M 18564 Disposed 2010-02-10 Common Shares (18564) Direct
2009-12-22 Option (right to buy) $41.0317 M 42561 Disposed 2014-02-19 Common Shares (42561) Direct
2009-12-22 Option (right to buy) $53.92 A 36449 Acquired 2014-02-19 Common Shares (36449) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Shares without par value 6152 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Plan as of December 21, 2009.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.

F3: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.